You need to enable JavaScript in order to use the AI chatbot tool powered by ChatBot
Print Page | Contact Us | Sign In | Join
Online CE Courses
Online CE Course List
How to use this list...

The online continuing education course list is in a table format which can be sorted by various headers across the top of the table: Title, Category, and Year. When you click a header the sort order will update either ascending or descending order. You can also use the search box below to find what you need. If you already registered, or have previously purchased CE Courses online, please login to our Learning Management System.

This list will be updated on a yearly basis.

To search the entire course list, please enter your search term below in the search box.
Questions? Please email our Education Manager
Topic Title Category Year Description
Regulatory An In-Depth Exploration into the Best Practices Considerations of the E14/S7B Q&A Guidance Regulatory 2024 Prior H et al (2009). Journal of Pharmacological and Toxicological Methods 60: 167-173. doi: 10.1016/j.vascn.2009.06.001
Cardiovascular Mini-Course: Cardiovascular Safety in Drug Development Cardiovascular 2024 Prior H et al (2009). Journal of Pharmacological and Toxicological Methods 60: 167-173. doi: 10.1016/j.vascn.2009.06.001
Toxicology Toxicology for the Safety Pharmacologist General, Toxicology 2024 Prior H et al (2009). Journal of Pharmacological and Toxicological Methods 60: 167-173. doi: 10.1016/j.vascn.2009.06.001
General Advances in In Vitro/Ex Vivo Assays General 2020 Prior H et al (2009). Journal of Pharmacological and Toxicological Methods 60: 167-173. doi: 10.1016/j.vascn.2009.06.001
Cardiovascular Blood Pressure: Mechanisms of Control, Beat-to-Beat Analysis and Translation to the Clinic Cardiovascular 2023 Prior H et al (2016). Journal of Pharmacological and Toxicological Methods 81: 75-87. doi.org/10.1016/j.vascn.2016.03.004
CNS CNS Biomarkers of Mood Disorders and Drug Abuse: Where Are We? CNS 2021 Prior H et al (2016). Journal of Pharmacological and Toxicological Methods 81: 75-87. doi.org/10.1016/j.vascn.2016.03.004
CNS Drug Abuse Liability Testing CNS 2011 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General How do the 3R principles apply in Safety Pharmacology Core Battery? General 2022 Skinner M et al (2019). Journal of Pharmacological and Toxicological Methods 96:87-94. doi: 10.1016/j.vascn.2019.02.005
Regulatory ICH E14/S7B Q7As Implementation for Practitioners Regulatory 2022 Skinner M et al (2019). Journal of Pharmacological and Toxicological Methods 96:87-94. doi: 10.1016/j.vascn.2019.02.005
General Imaging Technologies in Safety and Preclinical Research General 2020 Skinner M et al (2019). Journal of Pharmacological and Toxicological Methods 96:87-94. doi: 10.1016/j.vascn.2019.02.005
General Immunotherapy – Insights Into Immunogenicity and Immunotoxicology General 2021 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Microsampling Techniques and Novel Applications in Exposure Assessment General 2011 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Mini Course: Introduction and Overview to the Field of Safety Pharmacology General 2022 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Mini-Course: Organoids and their Applications General 2023 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
Regulatory Nonclinical Components of Integrated QTc Assessment Proposed in Emerging ICH E14/S7B Q&As Regulatory 2021 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
CNS Practical Application of CNS Safety Assessments: The Why, When, and How CNS 2023 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General SAFETY Biomarkers—What Every Safety Pharmacologist Should Know! General 2012 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Safety of Novel Therapeutic Modalities: Scientific Considerations and Regulatory Guidance General 2021 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Safety Pharmacology Considerations for Large Molecule and Novel Therapeutic Modalities General 2022 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Safety Pharmacology Endpoints in Toxicology Studies General 2012 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
Supplemental Safety Pharmacology of the Senses Supplemental 2020 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
Supplemental Supplemental Safety Pharmacology Studies Supplemental 2011 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General, Statistics The Power of Safety Pharmacology in Drug Development General, Statistics 2020 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Translational Science in Safety Pharmacology and Implications in the Clinic – Where Are We? General 2021 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Use of Artificial Intelligence (AI)/Machine Learning (ML) in Drug Development and Safety General 2020 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General, Statistics Variability, Uncertainty and Probability in Safety Pharmacology Decision Making General, Statistics 2019 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028
General Watch Your Tone: Intended and Unintended Effects on the Autonomic Nervous System and the Downstream Impact on Key Organ Systems General 2020 Berridge B et al (2016). iLAR journal 57: 120–132. doi: 10.1093/ilar/ilw028